300347 泰格医药
已收盘 08-17 15:00:00
资讯
新帖
简况
泰格医药新注册《泰格医药中心调研管理软件V1.0》项目的软件著作权
证券之星 · 08-14
泰格医药新注册《泰格医药中心调研管理软件V1.0》项目的软件著作权
泰格医药：截至目前，公司实际控制人尚未接到该事项的进一步通知
证券之星 · 08-11
泰格医药：截至目前，公司实际控制人尚未接到该事项的进一步通知
8月7日泰格医药涨9.51%，兴全商业模式LOF基金重仓该股
证券之星 · 08-07
8月7日泰格医药涨9.51%，兴全商业模式LOF基金重仓该股
港股开盘 | 恒指高开0.31% 医药CXO板块走强 药明康德(02359)涨近10%、中际旭创(03308)涨超9%
智通财经 · 08-04
港股开盘 | 恒指高开0.31% 医药CXO板块走强 药明康德(02359)涨近10%、中际旭创(03308)涨超9%
泰格医药（300347）披露回购公司股份进展公告，8月3日股价下跌0.72%
证券之星 · 08-03
泰格医药（300347）披露回购公司股份进展公告，8月3日股价下跌0.72%
泰格医药(03347)：截至7月末累计回购2096.3万股A股
智通财经 · 08-03
泰格医药(03347)：截至7月末累计回购2096.3万股A股
泰格医药：将于8月29日披露截至2026年6月30日公司股东人数
证券之星 · 08-03
泰格医药：将于8月29日披露截至2026年6月30日公司股东人数
7月29日泰格医药涨5.66%，兴全商业模式LOF基金重仓该股
证券之星 · 07-29
7月29日泰格医药涨5.66%，兴全商业模式LOF基金重仓该股
小摩增持泰格医药(03347)约56.66万股 每股作价约36.84港元
智通财经 · 07-23
小摩增持泰格医药(03347)约56.66万股 每股作价约36.84港元
7月15日泰格医药涨6.57%，中欧医疗健康混合A基金重仓该股
证券之星 · 07-15
7月15日泰格医药涨6.57%，中欧医疗健康混合A基金重仓该股
7月14日泰格医药涨6.08%，中欧医疗健康混合A基金重仓该股
证券之星 · 07-14
7月14日泰格医药涨6.08%，中欧医疗健康混合A基金重仓该股
泰格医药：截至2026年6月30日回购股份20,963,478股
证券之星 · 07-10
泰格医药：截至2026年6月30日回购股份20,963,478股
泰格医药：公司及实际控制人未收到中国证监会进一步立案事项相关通知书
证券之星 · 07-10
泰格医药：公司及实际控制人未收到中国证监会进一步立案事项相关通知书
大行评级丨大和：微降泰格医药目标价至44港元，评级升至“买入”
格隆汇 · 07-08
大行评级丨大和：微降泰格医药目标价至44港元，评级升至“买入”
Massachusetts Financial Services Company增持泰格医药(03347)15.9万股 每股作价34.9371港元
智通财经 · 07-07
Massachusetts Financial Services Company增持泰格医药(03347)15.9万股 每股作价34.9371港元
泰格医药（300347）披露证券变动月报表，7月6日股价上涨4.2%
证券之星 · 07-06
泰格医药（300347）披露证券变动月报表，7月6日股价上涨4.2%
泰格医药(03347)截至6月底累计回购2096.35万股A股
智通财经 · 07-02
泰格医药(03347)截至6月底累计回购2096.35万股A股
泰格医药：累计回购公司股份20963478股
证券日报网 · 07-02
泰格医药：累计回购公司股份20963478股
泰格医药：每10股派1.260000元，股权登记日为7月9日
南方财经网 · 07-02
泰格医药：每10股派1.260000元，股权登记日为7月9日
泰格医药：2026年7月22日将派发股息0.14468港元/股
南方财经网 · 06-30
泰格医药：2026年7月22日将派发股息0.14468港元/股
加载更多
公司概况
公司名称：
杭州泰格医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2012-08-17
主营业务：
杭州泰格医药科技股份有限公司的主营业务是为新药研发提供临床试验全过程专业服务的合同研究组织（CRO），为全球医药和医疗器械创新企业提供全面而综合的临床研究解决方案。公司的主要产品是临床运营、临床药理、注册与法规事务、科学事务、医学翻译、药物警戒、真实世界研究、第三方稽查、培训等服务、数据管理及统计分析、临床试验现场管理、受试者招募、医学影像、实验室。
发行价格：
37.88
{"stockData":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":55.18,"timestamp":1786950183000,"preClose":56.02,"halted":0,"volume":21235799,"delay":0,"changeRate":-0.015,"floatShares":566000000,"shares":861000000,"eps":0.896,"marketStatus":"已收盘","change":-0.84,"latestTime":"08-17 15:00:00","open":55.5,"high":55.97,"low":53.5,"amount":1163000000,"amplitude":0.0441,"askPrice":55.19,"askSize":49,"bidPrice":55.18,"bidSize":149,"shortable":0,"etf":0,"ttmEps":0.896,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787016600000},"marketStatusCode":5,"adr":0,"adjPreClose":56.02,"symbolType":"stock","openAndCloseTimeList":[[1786930200000,1786937400000],[1786942800000,1786950000000]],"highLimit":61.62,"lowLimit":50.42,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":861026050,"isCdr":false,"pbRate":2.31,"roa":"--","peRate":61.584821,"roe":"0.23%","epsLYR":1.04,"committee":0.703413,"marketValue":47511000000,"turnoverRate":0.0375,"status":1,"hkstockBrief":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":41.1,"timestamp":1786954109006,"preClose":41,"halted":0,"volume":1711937,"delay":0,"premium":"-35.97"},"floatMarketCap":31258000000},"requestUrl":"/m/hq/s/300347","defaultTab":"news","newsList":[{"id":"2659611141","title":"泰格医药新注册《泰格医药中心调研管理软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2659611141","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659611141?lang=zh_cn&edition=full","pubTime":"2026-08-14 02:23","pubTimestamp":1786645392,"startTime":"0","endTime":"0","summary":"证券之星消息，近日泰格医药（300347）新注册了《泰格医药中心调研管理软件V1.0》项目的软件著作权。今年以来泰格医药新注册软件著作权8个。结合公司2025年年报财务数据，2025年公司在研发方面投入了2.58亿元，同比增8.08%。通过天眼查大数据分析，杭州泰格医药科技股份有限公司共对外投资了60家企业，参与招投标项目53次；财产线索方面有商标信息79条，专利信息19条，著作权信息186条；此外企业还拥有行政许可47个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，不构成投资建议。相关 ETF","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400001467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1141","300347","LU1146622755.USD","BK1576","03347","BK0216","LU1820825898.SGD","BK0077","159180","BK0174","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658399311","title":"泰格医药：截至目前，公司实际控制人尚未接到该事项的进一步通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2658399311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658399311?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:33","pubTimestamp":1786437190,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药(300347)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问公司被调查的事项，进展到哪一步了？什么时候有个大的方向。泰格医药回复：投资者您好，截至目前，公司实际控制人尚未接到该事项的进一步通知。谢谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100025940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","300347","BK1576","BK0077","BK1583","LU1146622755.USD","03347","BK1141","BK0216","BK0028","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616131","title":"8月7日泰格医药涨9.51%，兴全商业模式LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657616131?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:48","pubTimestamp":1786092506,"startTime":"0","endTime":"0","summary":"证券之星消息，8月7日泰格医药涨9.51%，收盘报54.35元，换手率5.83%，成交量33.01万手，成交额17.29亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共85家，其中持有数量最多的公募基金为兴证全球基金的兴全商业模式LOF。兴全商业模式LOF的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700028189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","BK0028","BK1583","BK0216","BK1576","BK0174","300347","LU1146622755.USD","LU1820825898.SGD","BK1141","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656816586","title":"港股开盘 | 恒指高开0.31% 医药CXO板块走强 药明康德(02359)涨近10%、中际旭创(03308)涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656816586","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656816586?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:34","pubTimestamp":1785807258,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月4日，恒生指数高开0.31%，报26090.98点；恒生科技指数涨0.30%，报4890.34点。医药CXO板块大幅走强，药明康德涨近10%，药明生物涨超3%，昭衍新药涨近6%，凯莱英涨超5%，泰格医药涨近4%。药明康德此前披露半年报，上半年营收288.97亿元同比增长38.93%，并全面上调全年业绩指引。光通信板块活跃，中际旭创涨超9%。云计算及AI应用板块走高，金山云涨超5%。受隔夜美股科技板块走强带动，港股今日延续高开。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["WXXWY","03033","BK1149","HSTECH","LU0979878070.USD","LU0588546209.SGD","HHImain","LU0348735423.USD","LU2045819591.USD","LU0572944931.SGD","BK1583","HSI","LU0348825331.USD","LU0307460666.USD","LU0359201612.USD","LU0456846285.SGD","603127","LU0359202008.SGD","LU0516422366.SGD","06821","BK1576","03347","LU0326950275.SGD","BK1191","LU0348767384.USD","02269","BK1521","LU0043850808.USD","LU0348766576.USD","LU3063872942.SGD","09088","BK1589","07300","03032","LU0708995583.HKD","03115","07200","LU0051755006.USD","002821","BK1610","LU0140636845.USD","LU0052750758.USD","LU1794554557.SGD","LU2125910500.SGD","03419","07500","03067","LU0819121731.USD","IE00B0JY6N72.USD","07552","03308","300308","03037","09067","LU0417516902.SGD","03088","LU1242518931.SGD","LU2039709279.SGD","LU0516422952.EUR","07226","SG9999002463.SGD","LU0823426480.USD","02837","82800","LU0516422440.USD","LU1046422090.SGD","MCHmain","BK1122","02833","06127","LU0039217434.USD","SG9999002562.SGD","02359","LU0516423174.USD","83115","LU0823426308.USD","KURE","BK1249","LU1242518857.USD","LU2242644610.SGD","LU0181495838.USD","02800","09115","LU1688375341.USD","BK1533","LU1720050803.USD","03423","603259","LU0417516738.SGD","LU0516423091.SGD","LU0856984785.SGD","BK1141","300347","LU0327786744.USD","03417","LU1880383366.USD","LU0456827905.SGD","513600","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656372401","title":"泰格医药（300347）披露回购公司股份进展公告，8月3日股价下跌0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656372401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656372401?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:07","pubTimestamp":1785766049,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，泰格医药报收于49.63元，较前一交易日下跌0.72%，最新总市值为427.33亿元。该股当日开盘49.88元，最高50.51元，最低49.05元，成交额达5.53亿元，换手率为1.96%。公司于2026年8月3日披露《关于回购公司股份的进展公告》。公告显示，杭州泰格医药科技股份有限公司于2026年5月13日及6月9日召开董事会及股东大会，审议通过回购公司股份方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300036714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","BK1141","BK0077","LU1820825898.SGD","BK1576","BK0174","BK1583","BK0028","300347","BK0216","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375395","title":"泰格医药(03347)：截至7月末累计回购2096.3万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375395","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656375395?lang=zh_cn&edition=full","pubTime":"2026-08-03 19:19","pubTimestamp":1785755947,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布公告，截至2026年7月31日，公司通过股份回购专用证券账户以集中竞价交易方式回购公司股份2096.3万股，占公司目前总股本的2.4347%，占公司目前A股总股本的2.8410%。最高成交价为42.78元/股，最低成交价为38.22元/股，成交总金额为8.24亿元(不含交易费用)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475393.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159982","LU1146622755.USD","BK0174","300347","399300","BK1576","BK1583","LU1820825898.SGD","BK0077","BK1141","BK0028","03347","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656325019","title":"泰格医药：将于8月29日披露截至2026年6月30日公司股东人数","url":"https://stock-news.laohu8.com/highlight/detail?id=2656325019","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656325019?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:03","pubTimestamp":1785740599,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药(300347)08月03日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好：为了维护股价，希望公司能及时公布股东人数，比如截止7月25日股东人数是多少？泰格医药回复：投资者您好，公司将于8月29日披露的《2026年半年度报告》中相关章节公告截至2026年6月30日公司股东人数，请您关注公司于巨潮资讯网的公告。谢谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300013729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","LU1146622755.USD","BK1583","300347","BK0028","BK0077","LU1820825898.SGD","03347","BK0216","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655586852","title":"7月29日泰格医药涨5.66%，兴全商业模式LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2655586852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655586852?lang=zh_cn&edition=full","pubTime":"2026-07-29 16:44","pubTimestamp":1785314693,"startTime":"0","endTime":"0","summary":"证券之星消息，7月29日泰格医药涨5.66%，收盘报50.78元，换手率4.1%，成交量23.21万手，成交额11.63亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共85家，其中持有数量最多的公募基金为兴证全球基金的兴全商业模式LOF。兴全商业模式LOF的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900027493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK0077","LU1146622755.USD","BK0174","BK1583","BK0028","BK0216","LU1820825898.SGD","BK1141","300347","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653744779","title":"小摩增持泰格医药(03347)约56.66万股 每股作价约36.84港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653744779","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653744779?lang=zh_cn&edition=full","pubTime":"2026-07-23 19:20","pubTimestamp":1784805612,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，7月17日，小摩增持泰格医药(03347)56.6578万股，每股作价36.8414港元，总金额约为2087.35万港元。增持后最新持股数目约为2133.69万股，最新持股比例为17.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471552.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2381873111.SGD","LU0496365809.HKD","LU1244550221.USD","LU1116320901.HKD","IE00BJLML261.HKD","LU0943347566.SGD","BK1576","LU2023250504.SGD","LU2237443895.HKD","IE00BDRTCR15.USD","IYF","UYG","VFH","FNCL","LU0170899867.USD","XLF","LU1116320737.USD","LU1894683348.USD","FTXO","JPX","300347","03347","LU0267386448.USD","LU2430703095.HKD","KBWB","LU0689472784.USD","LU0203345920.USD","LU1496350171.SGD","TRUF","LU0345769128.USD","LU0964807845.USD","LU0320765646.SGD","IXG","LU1551013342.USD","TFNS","LU1720051108.HKD","LU0265550359.USD","LU2237443465.HKD","EWH","IE000M9KFDE8.USD","LU0820562030.AUD","IYG","LU1244550494.USD","LU1988902786.USD","LU0187121727.USD","BK4534","JPO","LU0345769631.USD","JPMO","IE00BKDWB100.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651455805","title":"7月15日泰格医药涨6.57%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651455805","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651455805?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:34","pubTimestamp":1784104451,"startTime":"0","endTime":"0","summary":"证券之星消息，7月15日泰格医药涨6.57%，收盘报51.9元，换手率7.07%，成交量40.03万手，成交额20.72亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共110家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值2.002，较上一交易日上涨3.85%，近一年上涨11.19%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500031174.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","LU1820825898.SGD","159760","BK1576","BK1583","300347","BK0077","BK0216","BK0174","03347","BK0028","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651517580","title":"7月14日泰格医药涨6.08%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651517580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651517580?lang=zh_cn&edition=full","pubTime":"2026-07-14 16:30","pubTimestamp":1784017855,"startTime":"0","endTime":"0","summary":"证券之星消息，7月14日泰格医药涨6.08%，收盘报48.7元，换手率4.86%，成交量27.54万手，成交额12.96亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共110家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为129.74亿元，最新净值1.9278，较上一交易日下跌1.21%，近一年上涨7.84%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400030847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","300347","159760","BK1576","LU1820825898.SGD","BK0077","BK0028","03347","BK0216","BK1141","BK1583","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650388761","title":"泰格医药：截至2026年6月30日回购股份20,963,478股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650388761","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650388761?lang=zh_cn&edition=full","pubTime":"2026-07-10 20:52","pubTimestamp":1783687924,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药07月09日在投资者关系平台上答复投资者关心的问题。泰格医药回复：投资者您好，截至2026 年6月30日，公司通过股份回购专用证券账户以集中竞价交易方式回购公司股份20,963,478 股，占公司目前总股本的2.4347%，占公司目前A 股总股本的2.8410%。公司后续将根据市场情况在回购期限内继续实施本次回购计划，并将在回购期间根据相关法律、法规和规范性文件的规定及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000042050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK0077","BK0174","LU1146622755.USD","BK1583","BK1141","LU1820825898.SGD","BK0216","BK0028","300347","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650138877","title":"泰格医药：公司及实际控制人未收到中国证监会进一步立案事项相关通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2650138877","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650138877?lang=zh_cn&edition=full","pubTime":"2026-07-10 20:52","pubTimestamp":1783687924,"startTime":"0","endTime":"0","summary":"证券之星消息，泰格医药07月09日在投资者关系平台上答复投资者关心的问题。截至目前，公司及实际控制人未收到中国证监会进一步立案事项相关通知书。公司后续将根据市场情况在回购期限内继续实施本次回购计划，并将在回购期间根据相关法律、法规和规范性文件的规定及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000042051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","BK1141","BK0028","300347","LU1820825898.SGD","03347","BK1576","BK0174","BK0216","BK1583","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649295062","title":"大行评级丨大和：微降泰格医药目标价至44港元，评级升至“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2649295062","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649295062?lang=zh_cn&edition=full","pubTime":"2026-07-08 13:32","pubTimestamp":1783488774,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1146622755.USD","BK1141","BK0216","BK1583","BK0077","BK1576","LU1820825898.SGD","BK0028","300347","BK0174","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649984928","title":"Massachusetts Financial Services Company增持泰格医药(03347)15.9万股 每股作价34.9371港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649984928","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649984928?lang=zh_cn&edition=full","pubTime":"2026-07-07 19:08","pubTimestamp":1783422512,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月2日，Massachusetts Financial Services Company增持泰格医药(03347)15.9万股，每股作价34.9371港元，总金额约为555.50万港元。增持后最新持股数目约为871.29万股，最新持股比例为7.08%。本交易涉及其他关联方：Sun Life Financial Inc.、Sun Life of Canada (U.S.) Financial Services Holdings, Inc.。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300347","BK0174","BK1141","LU1146622755.USD","BK1576","EWH","BK0216","BK0028","BK1583","BK0077","03347","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649627102","title":"泰格医药（300347）披露证券变动月报表，7月6日股价上涨4.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649627102","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649627102?lang=zh_cn&edition=full","pubTime":"2026-07-06 22:20","pubTimestamp":1783347625,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，泰格医药报收于48.9元，较前一交易日上涨4.2%，最新总市值为421.04亿元。该股当日开盘46.21元，最高50.66元，最低46.1元，成交额达13.91亿元，换手率为5.03%。近日，公司披露《H股公告-证券变动月报表》。公告显示，截至2026年6月30日，公司法定注册资本无变动，A股和H股的法定股本分别为737,901,250股和123,124,800股，每股面值人民币1元，总注册资本为861,026,050元。已发行股份中，A股减少20,963,478股，全部转为库存股，H股无变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600037494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","LU1146622755.USD","BK0216","03347","300347","BK1583","BK0077","161027","BK1576","BK0028","BK0174","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648685159","title":"泰格医药(03347)截至6月底累计回购2096.35万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648685159","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648685159?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:30","pubTimestamp":1783002647,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布公告，截至2026年6月30日，公司通过股份回购专用证券账户以集中竞价交易方式回购公司A股股份2096.35万股，占公司目前总股本的2.4347%，占公司目前A股总股本的2.8410%。最高成交价为42.78元/股，最低成交价为38.22元/股，成交总金额为8.24亿元(不含交易费用)。本次回购符合公司回购股份方案及相关法律法规的要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","300347","LU1146622755.USD","LU1820825898.SGD","BK0174","BK0028","399300","159982","BK1576","03347","BK1583","BK0077","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648688819","title":"泰格医药：累计回购公司股份20963478股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648688819","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648688819?lang=zh_cn&edition=full","pubTime":"2026-07-02 20:38","pubTimestamp":1782995880,"startTime":"0","endTime":"0","summary":"证券日报网讯7月2日，泰格医药发布公告称，截至2026年6月30日，公司通过股份回购专用证券账户以集中竞价交易方式回购公司股份20，963，478股，占公司目前总股本的2.4347%，占公司目前A股总股本的2.8410%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-02/doc-inifmrtu4043392.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-02/doc-inifmrtu4043392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1141","LU1146622755.USD","BK1576","BK0216","LU1820825898.SGD","BK1583","BK0028","BK0077","BK0174","300347","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648505031","title":"泰格医药：每10股派1.260000元，股权登记日为7月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2648505031","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648505031?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:29","pubTimestamp":1782984540,"startTime":"0","endTime":"0","summary":"南财智讯7月2日电，泰格医药发布2025年度权益分派实施公告，以本公告日A股总股本扣减公司回购专户持有股份后的可参与分配股数为基数，向全体股东每10股派发现金股利1.260000元（含税），共计派发现金红利8959.28万元（含税）；本次权益分派股权登记日为2026年7月9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607023791995677.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607023791995677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0077","BK0216","BK1141","LU1820825898.SGD","BK0028","BK1576","300347","03347","LU1146622755.USD","BK1583","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647555738","title":"泰格医药：2026年7月22日将派发股息0.14468港元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647555738","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647555738?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:12","pubTimestamp":1782821520,"startTime":"0","endTime":"0","summary":"南财智讯6月30日电，泰格医药（03347.HK）公告，公司将于2026年7月22日派发截至2025年12月31日止年度的末期股息，每股派发0.14468港元（按每10股1.4468港元折算）。本次股息以港元派发，除净日为2026年6月18日，记录日期为2026年6月26日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606303788557788.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606303788557788.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","03347","BK4588","300347","LU1146622755.USD","BK0077","VIG","BK0174","BK0216","EWH","BK0028","LU1820825898.SGD","BK4585","BK1141","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787008585661,"stockEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":0.1257},{"period":"3month","weight":0.2132},{"period":"6month","weight":-0.0911},{"period":"1year","weight":-0.2079},{"period":"ytd","weight":-0.0241}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.058},{"period":"3month","weight":-0.0448},{"period":"6month","weight":-0.0244},{"period":"1year","weight":0.0773},{"period":"ytd","weight":0.0035}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州泰格医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2012-08-17","address":"浙江省杭州市滨江区浦沿街道陆家潭街508号6层601-610室","registeredCapital":"86102万元","survey":" 杭州泰格医药科技股份有限公司的主营业务是为新药研发提供临床试验全过程专业服务的合同研究组织（CRO），为全球医药和医疗器械创新企业提供全面而综合的临床研究解决方案。公司的主要产品是临床运营、临床药理、注册与法规事务、科学事务、医学翻译、药物警戒、真实世界研究、第三方稽查、培训等服务、数据管理及统计分析、临床试验现场管理、受试者招募、医学影像、实验室。","listedPrice":37.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(300347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(300347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,300347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(300347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(300347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}